The International Diabetes Federation 2019 Congress has selected Mater’s Professor David McIntyre to provide the prestigious ‘Stream Award Lecture’ at this year’s meeting.
A $40,000 grant has been awarded to the Mater Research Institute—University of Queensland (MRI-UQ) to develop a parent-version of the national clinical guidelines on care around stillbirth.
Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for relapsed lymphoma patients.
Dr Seth Cheetham has been awarded three grants to fund research projects addressing the role of genomic plasticity in cancer treatment.
Cognitive Neurologist Professor Peter Nestor has been appointed to the position of Clinical Program Leader of the Neurosciences and Cognitive Health Program at Mater.
A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.
Simulation is a valuable tool used to educate and train health professionals.
Professor Vicki Flenady and her team at the Stillbirth Centre of Research Excellence (CRE) were awarded the UQ Faculty of Medicine Collaborators of the Year Award.
As of Thursday 24 January 2019 it will be a mandatory requirement for signatures to be collected in electronic format only on the Mater SSA.
Dr Peter Steer has commenced his appointment as Mater Group Chief Executive Officer.
Researchers from Mater Research have been awarded more than $1.84 million in National Health and Medical Research Council (NHMRC) funding.
Mater researchers have shown that new applications of existing drugs has the potential to improve quality of life for people with Myasthenia gravis